Baumgart, M. A., Wang, Y., Halmos, B., Presley, C. J., Dotan, E., Ganti, A. K., AL-Jumayli, M., Simon, M. A., Sandler, K., Brahmer, J. R. (2026). A randomized phase III trial of chemo-immunotherapy vs immunotherapy alone for the vulnerable older adult with advanced non–small cell lung cancer: The ACHIEVE study—ECOG-ACRIN EA5221.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps8674